Managers / Q1 2020 · view latest →
Global IMC LLC
CIK 0001741619 · 215 HIGHWAY 101, SUITE 216, SOLANA BEACH, CA, 92075 · 760-479-5080
Summary
Global Imc LLC reported $171M in U.S.-listed holdings across 101 positions for Q1 2020.
Its largest position, GLIN, represents 4.1% of the portfolio.
Compared with Q4 2019, the fund opened 44 new positions and exited 52.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 75.6% · $129M
- Other · 12.7% · $22M
- ADR · 5.8% · $10M
- ETP · 4.1% · $7M
- REIT · 1.8% · $3M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BLUBELLUS Health Inc. | NEW | +544.8K | 544.8K | +$5M | $5M |
| DQDaqo New Energy Corp. | NEW | +47.3K | 47.3K | +$3M | $3M |
| GDSGDS Holdings Limited | NEW | +43.8K | 43.8K | +$3M | $3M |
| American Software, Inc. | NEW | +155.5K | 155.5K | +$2M | $2M |
| Luminex Corporation | NEW | +77.3K | 77.3K | +$2M | $2M |
| PROFProfound Medical Corp. | NEW | +223.4K | 223.4K | +$2M | $2M |
| Perion Network Ltd. | NEW | +423.3K | 423.3K | +$2M | $2M |
| Orion Energy Systems, Inc. | NEW | +553.7K | 553.7K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | GLINVan Eck Associates Corporationhistory → | Funds - Equities ETF | 4.09% | $7M | 353.0K |
| 2 | BLUBELLUS Health Inc.history → | Common Stock | 3.18% | $5M | 544.8K |
| 3 | Sapiens International Corporation N.V. | Common Stock | 3.00% | $5M | 269.7K |
| 4 | Kornit Digital Ltd. | Common Stock | 2.03% | $3M | 139.3K |
| 5 | ChemoCentryx, Inc. | Common Stock | 1.78% | $3M | 75.8K |
| 6 | AXSMAxsome Therapeutics, Inc.history → | Common Stock | 1.74% | $3M | 50.6K |
| 7 | PLUGPlug Power Inc.history → | Common Stock | 1.71% | $3M | 826.0K |
| 8 | NVMINova Measuring Instruments Ltd.history → | Common Stock | 1.63% | $3M | 85.6K |
| 9 | DQDaqo New Energy Corp.history → | Common Stock | 1.60% | $3M | 47.3K |
| 10 | Karyopharm Therapeutics Inc. | Common Stock | 1.53% | $3M | 136.4K |
| 11 | PRNBPrincipia Biopharma Inc.history → | Common Stock | 1.51% | $3M | 43.4K |
| 12 | GDSGDS Holdings Limitedhistory → | Common Stock | 1.49% | $3M | 43.8K |
| 13 | DAVAENDAVA PLChistory → | Common Stock | 1.42% | $2M | 69.0K |
| 14 | Safehold Inc. | Common Stock | 1.41% | $2M | 38.1K |
| 15 | KODKODIAK SCIENCEShistory → | Common Stock | 1.39% | $2M | 49.7K |
| 16 | AUPHAurinia Pharmaceuticals Inc.history → | Common Stock | 1.33% | $2M | 157.1K |
| 17 | American Software, Inc. | Common Stock | 1.29% | $2M | 155.5K |
| 18 | EVEREVERQUOTE INChistory → | Common Stock | 1.26% | $2M | 82.3K |
| 19 | RADA Electronic Industries Ltd. | Common Stock | 1.26% | $2M | 614.1K |
| 20 | KDMNKadmon Holdings, Inc.history → | Common Stock | 1.25% | $2M | 511.0K |
| 21 | Luminex Corporation | Common Stock | 1.24% | $2M | 77.3K |
| 22 | PROFProfound Medical Corp.history → | Common Stock | 1.24% | $2M | 223.4K |
| 23 | COLLCollegium Pharmaceutical, Inc.history → | Common Stock | 1.24% | $2M | 130.0K |
| 24 | RDVTRED VIOLET INChistory → | Common Stock | 1.22% | $2M | 115.8K |
| 25 | Perion Network Ltd. | Common Stock | 1.21% | $2M | 423.3K |
| 26 | Orion Energy Systems, Inc. | Common Stock | 1.20% | $2M | 553.7K |
| 27 | KIDSOrthoPediatrics Corp.history → | Common Stock | 1.19% | $2M | 51.5K |
| 28 | KARUNA THERAPEUTIC | Common Stock | 1.14% | $2M | 27.1K |
| 29 | LUNALuna Innovations Incorporatedhistory → | Common Stock | 1.13% | $2M | 315.3K |
| 30 | EIDOS THERAPEUTICS | Common Stock | 1.10% | $2M | 38.5K |
| 31 | ASPUAspen Group, Inc.history → | Common Stock | 1.10% | $2M | 234.5K |
| 32 | iCAD, Inc. | Common Stock | 1.05% | $2M | 245.6K |
| 33 | CWSTCasella Waste Systems, Inc.history → | Common Stock | 1.05% | $2M | 45.8K |
| 34 | ARDXArdelyx, Inc.history → | Common Stock | 1.05% | $2M | 314.3K |
| 35 | ATRCAtriCure, Inc.history → | Common Stock | 1.01% | $2M | 51.4K |
| 36 | RPAYREPAY HLDGS CORPhistory → | Common Stock | 1.00% | $2M | 119.2K |
| 37 | CRNCCERENCE INC | Common Stock | 0.99% | $2M | 109.5K |
| 38 | CSTLCastle Biosciences, Inc. | Common Stock | 0.98% | $2M | 56.5K |
| 39 | INSPInspire Medical Systems, Inc. | Common Stock | 0.98% | $2M | 27.9K |
| 40 | ZYXIQZynex, Inc. | Common Stock | 0.97% | $2M | 150.5K |
| 41 | SPTSprout Social, Inc. | Common Stock | 0.96% | $2M | 102.9K |
| 42 | Revance Therapeutics, Inc. | Common Stock | 0.95% | $2M | 109.9K |
| 43 | UTIUniversal Technical Institute, Inc. | Common Stock | 0.95% | $2M | 273.3K |
| 44 | Dicerna Pharmaceuticals, Inc. | Common Stock | 0.95% | $2M | 88.5K |
| 45 | SITMMegaChips Corporation | Common Stock | 0.94% | $2M | 74.0K |
| 46 | PLMRPALOMAR HOLDINGS | Common Stock | 0.94% | $2M | 27.6K |
| 47 | AMRCAmeresco, Inc. | Common Stock | 0.94% | $2M | 94.4K |
| 48 | Bioxcel Therapeutics, Inc. | Common Stock | 0.94% | $2M | 71.8K |
| 49 | SilverCrest Metals Inc. | Common Stock | 0.92% | $2M | 302.7K |
| 50 | VVXVectrus, Inc. | Common Stock | 0.91% | $2M | 37.4K |
| 51 | CELHCelsius Holdings, Inc. | Common Stock | 0.91% | $2M | 368.3K |
| 52 | Limelight Networks, Inc. | Common Stock | 0.90% | $2M | 270.2K |
| 53 | CEVACEVA, Inc. | Common Stock | 0.87% | $1M | 59.8K |
| 54 | the Rubicon Project, Inc. | Common Stock | 0.86% | $1M | 264.9K |
| 55 | PEWPCTEL, Inc. | Common Stock | 0.86% | $1M | 221.0K |
| 56 | KRMDRepro Med Systems, Inc. | Common Stock | 0.85% | $1M | 193.0K |
| 57 | SeaChange International, Inc. | Common Stock | 0.83% | $1M | 380.3K |
| 58 | TRNSTranscat, Inc. | Common Stock | 0.81% | $1M | 52.4K |
| 59 | Pfenex Inc. | Common Stock | 0.80% | $1M | 155.7K |
| 60 | AGYSAgilysys, Inc. | Common Stock | 0.80% | $1M | 81.4K |
| 61 | ACHOwens & Minor, Inc. | Common Stock | 0.79% | $1M | 147.4K |
| 62 | Adverum Biotechnologies, Inc. | Common Stock | 0.79% | $1M | 137.6K |
| 63 | NATNordic American Tankers Limited | Common Stock | 0.78% | $1M | 295.8K |
| 64 | APREA THERAPEUTICS | Common Stock | 0.78% | $1M | 38.3K |
| 65 | OCULOcular Therapeutix, Inc. | Common Stock | 0.77% | $1M | 265.3K |
| 66 | PROVENTION BIO INC | Common Stock | 0.77% | $1M | 142.2K |
| 67 | KRYSKrystal Biotech, Inc. | Common Stock | 0.76% | $1M | 30.1K |
| 68 | FLGTFulgent Genetics, Inc. | Common Stock | 0.76% | $1M | 120.2K |
| 69 | DHTDHT Holdings, Inc. | Common Stock | 0.75% | $1M | 168.0K |
| 70 | SPWHSportsman's Warehouse Holdings, Inc. | Common Stock | 0.75% | $1M | 208.7K |
| 71 | Model N, Inc. | Common Stock | 0.75% | $1M | 57.6K |
| 72 | LKNCYLUCKIN COFFEE INC | Common Stock | 0.75% | $1M | 46.9K |
| 73 | Inseego Corp. | Common Stock | 0.73% | $1M | 200.7K |
| 74 | OSUROraSure Technologies, Inc. | Common Stock | 0.72% | $1M | 113.7K |
| 75 | Infinera Corporation | Common Stock | 0.71% | $1M | 230.2K |
| 76 | GRWGGROWGENERATION COR | Common Stock | 0.71% | $1M | 318.6K |
| 77 | ADUSAddus HomeCare Corporation | Common Stock | 0.70% | $1M | 17.8K |
| 78 | PHRPhreesia, Inc. | Common Stock | 0.65% | $1M | 53.0K |
| 79 | NanoString Technologies, Inc. | Common Stock | 0.63% | $1M | 44.5K |
| 80 | RILYB. Riley Financial, Inc. | Common Stock | 0.62% | $1M | 57.2K |
| 81 | XPELXPEL, Inc. | Common Stock | 0.61% | $1M | 104.4K |
| 82 | ACMRACM Research, Inc. | Common Stock | 0.61% | $1M | 35.0K |
| 83 | Spartan Motors, Inc. | Common Stock | 0.59% | $1M | 78.0K |
| 84 | FORMFormFactor, Inc. | Common Stock | 0.59% | $1M | 50.0K |
| 85 | Sharps Compliance Corp. | Common Stock | 0.58% | $998,000 | 125.7K |
| 86 | Kala Pharmaceuticals, Inc. | Common Stock | 0.58% | $989,000 | 112.5K |
| 87 | MIRMMIRUM PHARMACEUTIC | Common Stock | 0.57% | $969,000 | 69.2K |
| 88 | NWPXNorthwest Pipe Company | Common Stock | 0.56% | $962,000 | 43.2K |
| 89 | NextCure, Inc. | Common Stock | 0.54% | $930,000 | 25.1K |
| 90 | ZLABZAI LAB LTD | Common Stock | 0.53% | $900,000 | 17.5K |
| 91 | PARPAR Technology Corporation | Common Stock | 0.49% | $845,000 | 65.7K |
| 92 | PLABPhotronics, Inc. | Common Stock | 0.49% | $837,000 | 81.6K |
| 93 | Reata Pharmaceuticals, Inc. | Common Stock | 0.44% | $747,000 | 5.2K |
| 94 | Global Medical REIT Inc. | Common Stock | 0.39% | $674,000 | 66.6K |
| 95 | DSGRLawson Products, Inc. | Common Stock | 0.39% | $670,000 | 25.1K |
| 96 | ACLSAxcelis Technologies, Inc. | Common Stock | 0.38% | $656,000 | 35.8K |
| 97 | PFSIPennyMac Financial Services, Inc. | Common Stock | 0.38% | $656,000 | 29.7K |
| 98 | CTSOCytosorbents Corporation | Common Stock | 0.28% | $478,000 | 61.8K |
| 99 | COHUCohu, Inc. | Common Stock | 0.17% | $286,000 | 23.1K |
| 100 | IIIVI3 VERTICALS INC | Common Stock | 0.16% | $273,000 | 14.3K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $47M | 16 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $23M | 9 | Feb 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $24M | 11 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $386M | 80 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $367M | 80 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $557M | 121 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $496M | 99 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $445M | 88 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $433M | 89 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $414M | 98 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $370M | 98 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $340M | 81 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $356M | 81 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $387M | 175 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $376M | 172 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $407M | 179 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $542M | 198 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $563M | 194 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $423M | 187 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $361M | 141 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $361M | 139 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $369M | 130 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $273M | 125 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $222M | 118 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $171M | 101 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $250M | 109 | Feb 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $205M | 113 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $235M | 124 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $226M | 124 | May 10, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $183M | 126 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.